U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288749) titled 'Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.' on Dec. 05.
Brief Summary: Evaluating the safety and efficacy of glimepiride in patients with type 2 diabetes and chronic heart failure with reduced ejection fraction--a multicenter randomized controlled study.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes Mellitus (T2DM)
Chronic Heart Failure (CHF)
Intervention:
DRUG: Glimepiride (oral)
Standardized treatment for chronic heart failure + standardized treatment for type 2 diabetes + oral glimepiride (ini...